Molecular Identity
Tobramycin
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
PubChem CID: 36294
Tobramycin Sulfate can cause developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C18H37N5O9
Molecular Formula
467.50
Molecular Weight
g/mol
467.2591
Exact Mass
Da
-6.2
XLogP
Drug-like (Lipinski: < 5)
268
TPSA
May have limited oral absorption
10
H-Bond Donors
14
H-Bond Acceptors
609
Complexity
SMILES
Canonical SMILES
SMILES: C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)NIsomeric SMILES
SMILES: C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)NSynonyms(20)
tobramycin32986-56-4Nebramycin VINebramycin 6Nebramycin factor 6Deoxykanamycin BTobrexTobi3'-Deoxykanamycin BAktobTobralexTobramicinaTobi PodhalervantobraTobramycine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tobramycin
Loading drug network...